Metreleptin Doesn’t Improve Glycemic Control in T1DM
Metreleptin associated with modest reductions in body weight and daily insulin dose
Most Health Care Providers Can Offer Cost Estimate
Although 75 percent of provider organizations can offer estimate, only 25% of patients request one
Judgement Bias in Medical Device Recall Decisions
Decision makers in firms either over-react or under-react, researchers say
Reduced Health Care Use for Exenatide Regimens in T2DM
Reduced costs for patients with exenatide-based regimens prescribed once weekly or twice daily
Cognitive Outcomes in Children No Better With Levothyroxine Tx
Subclinical hypothyroidism, hypothyroxinemia tx in pregnancy not linked to improved outcomes
Overall, 8.8 Percent of U.S. Population Uninsured in 2016
In first nine months of 2016, 12.3 percent of adults aged 18 to 64 and 5 percent of children uninsured
February 2017 Briefing – Diabetes & Endocrinology
Here are what the editors at HealthDay consider to be the most important developments in Diabetes & Endocrinology for February 2017. This roundup includes...
Poor Knowledge of Charcot Neuroarthropathy Reported
Clinicians with better knowledge of CN more likely to provide correct initial management
Complication Rates Often Higher in Youth With T2DM Versus T1DM
However, no longer an excess of complications for type 2 diabetes after controlling for obesity
Higher Dietary Potassium to Sodium Ratio Can Lower CVD Risk
Research supports public health efforts for increasing consumption of natural potassium rich foods
